Header Logo

Andrea Madrigrano

Concepts (96)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
17
2023
353
6.510
Why?
Mastectomy
7
2023
21
1.660
Why?
Antineoplastic Agents, Hormonal
2
2019
14
1.250
Why?
Carcinoma, Squamous Cell
2
2019
160
1.060
Why?
Li-Fraumeni Syndrome
1
2022
2
0.840
Why?
Neoplasms, Radiation-Induced
1
2022
11
0.830
Why?
Triple Negative Breast Neoplasms
1
2022
16
0.790
Why?
Mammaplasty
1
2021
4
0.770
Why?
Genetic Predisposition to Disease
1
2023
373
0.750
Why?
Female
18
2023
14399
0.720
Why?
Retrospective Studies
10
2023
3299
0.710
Why?
Hypercalcemia
1
2019
10
0.650
Why?
Referral and Consultation
2
2021
78
0.640
Why?
Carcinoma, Ductal
1
2019
5
0.640
Why?
Breast Neoplasms, Male
1
2019
9
0.640
Why?
Tamoxifen
1
2019
24
0.630
Why?
Stromal Cells
1
2018
31
0.610
Why?
Humans
20
2023
26028
0.600
Why?
Disease Management
2
2019
108
0.600
Why?
Hemangiosarcoma
1
2017
8
0.590
Why?
Practice Patterns, Physicians'
1
2018
104
0.570
Why?
Patient Compliance
1
2018
145
0.560
Why?
Inflammatory Breast Neoplasms
1
2016
4
0.550
Why?
Mastectomy, Segmental
1
2016
13
0.540
Why?
Body Mass Index
1
2019
412
0.540
Why?
Antibiotic Prophylaxis
1
2016
31
0.530
Why?
Uterine Cervical Neoplasms
1
2016
34
0.530
Why?
Practice Guidelines as Topic
1
2018
291
0.530
Why?
Obesity
1
2019
277
0.520
Why?
Surgical Wound Infection
1
2016
81
0.510
Why?
Carcinoma, Lobular
1
2015
18
0.480
Why?
Carcinoma, Ductal, Breast
1
2015
28
0.480
Why?
Aged
7
2023
8705
0.470
Why?
Image Processing, Computer-Assisted
1
2015
186
0.450
Why?
Neoplasm Staging
3
2022
313
0.440
Why?
Decision Making
1
2015
222
0.410
Why?
Aged, 80 and over
5
2022
4660
0.410
Why?
Skin Neoplasms
2
2016
67
0.410
Why?
Oocytes
2
2009
6
0.380
Why?
Cryopreservation
2
2009
17
0.380
Why?
Postoperative Complications
1
2016
862
0.350
Why?
Case-Control Studies
2
2023
550
0.330
Why?
Follow-Up Studies
3
2019
1712
0.310
Why?
Sarcoma, Alveolar Soft Part
1
2008
1
0.300
Why?
Infertility, Female
1
2007
12
0.290
Why?
Quality of Life
2
2022
609
0.280
Why?
Adult
7
2022
7364
0.280
Why?
Prognosis
2
2019
750
0.230
Why?
Postoperative Nausea and Vomiting
1
2023
16
0.220
Why?
Time Factors
4
2019
1365
0.200
Why?
Early Detection of Cancer
1
2023
85
0.200
Why?
Sentinel Lymph Node Biopsy
2
2019
16
0.200
Why?
Mutation
1
2023
311
0.190
Why?
Length of Stay
1
2023
302
0.190
Why?
Middle Aged
4
2023
8509
0.170
Why?
Chemotherapy, Adjuvant
2
2018
70
0.170
Why?
Acellular Dermis
1
2019
6
0.170
Why?
Breast Implantation
1
2019
3
0.170
Why?
Breast Implants
1
2019
5
0.160
Why?
Treatment Outcome
2
2019
3293
0.160
Why?
Mammography
1
2019
47
0.160
Why?
Combined Modality Therapy
1
2019
277
0.150
Why?
Phyllodes Tumor
1
2017
1
0.150
Why?
Rare Diseases
1
2017
11
0.150
Why?
Fatal Outcome
1
2016
50
0.140
Why?
Needles
1
2016
19
0.130
Why?
Age Factors
1
2018
744
0.130
Why?
Biopsy
1
2015
199
0.120
Why?
Anti-Bacterial Agents
1
2016
340
0.110
Why?
Magnetic Resonance Imaging
1
2018
1140
0.110
Why?
Tomography, X-Ray Computed
1
2015
713
0.090
Why?
Young Adult
1
2016
1853
0.090
Why?
Amenorrhea
1
2009
1
0.090
Why?
Embryo, Mammalian
1
2009
22
0.090
Why?
Antineoplastic Agents
1
2009
176
0.070
Why?
Tissue and Organ Harvesting
1
2007
16
0.070
Why?
Ultrasonography
1
2008
222
0.070
Why?
Male
1
2019
14011
0.050
Why?
Adolescent
1
2008
2064
0.050
Why?
Radiologists
1
2019
6
0.040
Why?
Esthetics
1
2019
11
0.040
Why?
Pectoralis Muscles
1
2019
17
0.040
Why?
Margins of Excision
1
2019
27
0.040
Why?
Intraoperative Care
1
2019
37
0.040
Why?
Operative Time
1
2019
83
0.040
Why?
Cost-Benefit Analysis
1
2019
124
0.040
Why?
Postoperative Care
1
2019
128
0.040
Why?
Wound Healing
1
2019
146
0.040
Why?
Surgeons
1
2019
76
0.040
Why?
Pilot Projects
1
2019
378
0.040
Why?
Imaging, Three-Dimensional
1
2019
216
0.040
Why?
Databases, Factual
1
2019
325
0.040
Why?
Risk Assessment
1
2019
622
0.030
Why?
Prosthesis Failure
1
2019
506
0.030
Why?
Cohort Studies
1
2019
1823
0.030
Why?
Neoadjuvant Therapy
1
2009
63
0.020
Why?
Madrigrano's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (96)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_